Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial

Details 詳細情報について

• CRID

  1360017285982153216

• DOI

  10.1016/j.eclinm.2021.101152

• ISSN

  25895370

• Web Site

  https://api.elsevier.com/content/article/PII:S2589537021004326?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S2589537021004326?httpAccept=text/plain

• Data Source

  • Crossref